10-K/A

FORM 10-K/A

Company: Viridian Therapeutics, Inc.\DE
Filed: August 18, 2016
Period of Report: December 31, 2015
Accession Number: 0001171843-16-011862

View Document ↗ View on SEC.gov ↗